|
DE69638122D1
(de)
*
|
1996-09-04 |
2010-03-18 |
Intertrust Tech Corp |
Zuverlässige Infrastrukturhilfssysteme, Verfahren und Techniken für sicheren elektronischen Handel, elektronische Transaktionen, Handelsablaufsteuerung und Automatisierung, verteilte Verarbeitung und Rechteverwaltung
|
|
WO2008014199A2
(en)
|
2006-07-28 |
2008-01-31 |
Boehringer Ingelheim International Gmbh |
Sulfonyl compounds which modulate the cb2 receptor
|
|
AU2007287428B2
(en)
|
2006-08-24 |
2011-08-11 |
Astrazeneca Ab |
Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
|
|
WO2008039645A1
(en)
|
2006-09-25 |
2008-04-03 |
Boehringer Ingelheim International Gmbh |
Compounds which modulate the cb2 receptor
|
|
WO2008086014A2
(en)
*
|
2007-01-09 |
2008-07-17 |
Amgen Inc. |
Bis-aryl amide derivatives useful for the treatment of cancer
|
|
KR20090108124A
(ko)
*
|
2007-02-06 |
2009-10-14 |
노파르티스 아게 |
Ｐｉ 3-키나제 억제제 및 그의 사용 방법
|
|
JP5508260B2
(ja)
*
|
2007-07-09 |
2014-05-28 |
アストラゼネカ アクチボラグ |
ｍＴＯＲキナーゼおよび／またはＰ１３Ｋに関連する病気に用いられるモルホリノピリミジン誘導体
|
|
JP2010533158A
(ja)
*
|
2007-07-09 |
2010-10-21 |
アストラゼネカ アクチボラグ |
化合物類−９４５
|
|
CA2704684A1
(en)
|
2007-11-07 |
2009-05-14 |
Boehringer Ingelheim International Gmbh |
Compounds which modulate the cb2 receptor
|
|
JP5581219B2
(ja)
|
2008-01-25 |
2014-08-27 |
ミレニアム ファーマシューティカルズ， インコーポレイテッド |
チオフェンおよびホスファチジルイノシトール３−キナーゼ（ｐｉ３ｋ）阻害薬としてのその使用
|
|
US8946439B2
(en)
|
2008-02-29 |
2015-02-03 |
Evotec Ag |
Amide compounds, compositions and uses thereof
|
|
US20120015988A1
(en)
*
|
2008-05-13 |
2012-01-19 |
Boehringer Ingelheim International Gmbh |
Sulfone Compounds Which Modulate The CB2 Receptor
|
|
UA99361C2
(uk)
|
2008-05-23 |
2012-08-10 |
Уайт Елелсі |
ТРИАЗИНИ ЯК ІНГІБІТОРИ PІ3-КІНАЗИ І mTOR
|
|
JP5596026B2
(ja)
|
2008-06-19 |
2014-09-24 |
ミレニアム ファーマシューティカルズ， インコーポレイテッド |
チオフェン又はチアゾール誘導体及びｐｉ３ｋ阻害剤としてのそれらの使用
|
|
JP5749162B2
(ja)
|
2008-07-10 |
2015-07-15 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｃｂ２受容体を調節するスルホン化合物
|
|
AR073354A1
(es)
|
2008-07-31 |
2010-11-03 |
Genentech Inc |
Compuestos de pirimidina, composiciones farmaceuticas y su uso en el tratamiento del cancer.
|
|
ES2412780T3
(es)
|
2008-09-10 |
2013-07-12 |
Mitsubishi Tanabe Pharma Corporation |
Compuestos aromáticos de anillo de 6 miembros que contiene nitrógeno y su uso
|
|
CA2737038A1
(en)
|
2008-09-18 |
2010-03-25 |
Evotec Ag |
Amide compounds, compositions and uses thereof
|
|
CN102164917A
(zh)
|
2008-09-25 |
2011-08-24 |
贝林格尔.英格海姆国际有限公司 |
选择性调节cb2受体的磺酰基化合物
|
|
TWI378933B
(en)
|
2008-10-14 |
2012-12-11 |
Daiichi Sankyo Co Ltd |
Morpholinopurine derivatives
|
|
TW201028410A
(en)
|
2008-12-22 |
2010-08-01 |
Astrazeneca Ab |
Chemical compounds 610
|
|
US9139589B2
(en)
|
2009-01-30 |
2015-09-22 |
Millennium Pharmaceuticals, Inc. |
Heteroaryls and uses thereof
|
|
US9090601B2
(en)
|
2009-01-30 |
2015-07-28 |
Millennium Pharmaceuticals, Inc. |
Thiazole derivatives
|
|
US8796314B2
(en)
|
2009-01-30 |
2014-08-05 |
Millennium Pharmaceuticals, Inc. |
Heteroaryls and uses thereof
|
|
ES2529205T3
(es)
|
2009-03-13 |
2015-02-17 |
Cellzome Limited |
Derivados de pirimidina como inhibidores de mTOR
|
|
WO2010120991A1
(en)
*
|
2009-04-17 |
2010-10-21 |
Wyeth Llc |
5, 6, 7, 8-tetrahydropyrido[4,3-d]pyrimidine compounds, their use as mtor, pi3, and hsmg-1 kinase inhibitors, and their syntheses
|
|
EP2419432B9
(en)
*
|
2009-04-17 |
2016-02-17 |
Wyeth LLC |
Pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
|
|
WO2010120996A1
(en)
*
|
2009-04-17 |
2010-10-21 |
Wyeth Llc |
5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
|
|
JPWO2010125799A1
(ja)
*
|
2009-04-27 |
2012-10-25 |
塩野義製薬株式会社 |
Ｐｉ３ｋ阻害活性を有するウレア誘導体
|
|
US8299103B2
(en)
|
2009-06-15 |
2012-10-30 |
Boehringer Ingelheim International Gmbh |
Compounds which selectively modulate the CB2 receptor
|
|
US8383615B2
(en)
|
2009-06-16 |
2013-02-26 |
Boehringer Ingelheim International Gmbh |
Azetidine 2-carboxamide derivatives which modulate the CB2 receptor
|
|
AP3631A
(en)
*
|
2009-06-17 |
2016-03-08 |
Vertex Pharma |
Inhibitors of influenza viruses replication
|
|
SG176959A1
(en)
*
|
2009-06-24 |
2012-01-30 |
Genentech Inc |
Oxo-heterocycle fused pyrimidine compounds, compositions and methods of use
|
|
US8383651B2
(en)
|
2009-09-22 |
2013-02-26 |
Boehringer Ingelheim International Gmbh |
Compounds which selectively modulate the CB2 receptor
|
|
MX2012005023A
(es)
|
2009-10-30 |
2012-06-19 |
Ariad Pharma Inc |
Metodos y composiciones para tratar cancer.
|
|
JP5579864B2
(ja)
|
2009-11-12 |
2014-08-27 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
Ｎ−９−置換プリン化合物、組成物及び使用の方法
|
|
US8828990B2
(en)
|
2009-11-12 |
2014-09-09 |
Genentech, Inc. |
N-7 substituted purine and pyrazolopyrimine compounds, compositions and methods of use
|
|
US9315491B2
(en)
|
2009-12-28 |
2016-04-19 |
Development Center For Biotechnology |
Pyrimidine compounds as mTOR and PI3K inhibitors
|
|
EP2523936A1
(en)
|
2010-01-15 |
2012-11-21 |
Boehringer Ingelheim International GmbH |
Compounds which modulate the cb2 receptor
|
|
WO2011107585A1
(en)
|
2010-03-04 |
2011-09-09 |
Cellzome Limited |
Morpholino substituted urea derivatives as mtor inhibitors
|
|
US8329735B2
(en)
|
2010-03-05 |
2012-12-11 |
Boehringer Ingelheim International Gmbh |
Tetrazole compounds which selectively modulate the CB2 receptor
|
|
SA111320519B1
(ar)
|
2010-06-11 |
2014-07-02 |
Astrazeneca Ab |
مركبات بيريميدينيل للاستخدام كمثبطات atr
|
|
WO2012012307A1
(en)
|
2010-07-22 |
2012-01-26 |
Boehringer Ingelheim International Gmbh |
Sulfonyl compounds which modulate the cb2 rece
|
|
WO2012021696A1
(en)
|
2010-08-11 |
2012-02-16 |
Millennium Pharmaceuticals, Inc. |
Heteroaryls and uses thereof
|
|
WO2012021611A1
(en)
|
2010-08-11 |
2012-02-16 |
Millennium Pharmaceuticals, Inc. |
Heteroaryls and uses thereof
|
|
US8859768B2
(en)
|
2010-08-11 |
2014-10-14 |
Millennium Pharmaceuticals, Inc. |
Heteroaryls and uses thereof
|
|
HUE041326T2
(hu)
|
2010-10-01 |
2019-05-28 |
Novartis Ag |
5-(2,6-di-4-morfolinil-4-piridmidinil)-4-trifluorometilpiridin-2-amin kristályformái, egy PIK3 inhibitor
|
|
CN103237450A
(zh)
|
2010-10-13 |
2013-08-07 |
米伦纽姆医药公司 |
杂芳基化合物和其用途
|
|
US8440662B2
(en)
|
2010-10-31 |
2013-05-14 |
Endo Pharmaceuticals, Inc. |
Substituted quinazoline and pyrido-pyrimidine derivatives
|
|
US20140163023A1
(en)
|
2011-04-04 |
2014-06-12 |
Cellzome Limited |
Dihydropyrrolo pyrimidine derivatives as mtor inhibitors
|
|
CN102887867B
(zh)
*
|
2011-07-21 |
2015-04-15 |
中国科学院上海药物研究所 |
一类三嗪类化合物、该化合物的制备方法及其用途
|
|
CN103842357A
(zh)
*
|
2011-07-26 |
2014-06-04 |
格吕伦塔尔有限公司 |
作为类香草素受体配体的被取代的、含有杂芳环吡唑的羧酰胺和脲衍生物
|
|
UA118010C2
(uk)
|
2011-08-01 |
2018-11-12 |
Вертекс Фармасьютікалз Інкорпорейтед |
Інгібітори реплікації вірусів грипу
|
|
EP3255041A1
(en)
*
|
2011-09-02 |
2017-12-13 |
Purdue Pharma L.P. |
Pyrimidines as sodium channel blockers
|
|
ES2609606T3
(es)
|
2011-09-21 |
2017-04-21 |
Cellzome Limited |
Derivados de urea y carbamato de 2-morfolino-1,3,5-triazina como inhibidores de mTOR para el tratamiento de enfermedades inmunológicas o proliferativas
|
|
MX341577B
(es)
|
2011-10-07 |
2016-08-25 |
Cellzome Ltd |
Derivados biciclicos de pirimidin-urea o carbamato sustituidos con morfolino como inhibidores del blanco de rapamicina de mamifero.
|
|
KR20160027219A
(ko)
|
2012-05-23 |
2016-03-09 |
에프. 호프만-라 로슈 아게 |
내배엽 및 간세포를 수득하고 사용하는 조성물 및 방법
|
|
EP2803668A1
(en)
|
2013-05-17 |
2014-11-19 |
Boehringer Ingelheim International Gmbh |
Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
|
|
US9296727B2
(en)
|
2013-10-07 |
2016-03-29 |
Vertex Pharmaceuticals Incorporated |
Methods of regioselective synthesis of 2,4-disubstituted pyrimidines
|
|
KR102338461B1
(ko)
|
2013-11-13 |
2021-12-13 |
버텍스 파마슈티칼스 인코포레이티드 |
인플루엔자 바이러스 복제 억제제의 제조 방법
|
|
RU2700415C1
(ru)
|
2013-11-13 |
2019-09-17 |
Вертекс Фармасьютикалз Инкорпорейтед |
Ингибиторы репликации вирусов гриппа
|
|
DK3145916T3
(da)
*
|
2014-05-21 |
2020-05-11 |
Allergan Inc |
Imidazolderivater som formylpeptidreceptormodulatorer
|
|
MY195016A
(en)
|
2014-08-04 |
2023-01-03 |
Nuevolution As |
Optionally Fused Heterocyclyl-Substituted Derivatives of Pyrimidine Useful for The Treatment of Inflammatory, Metabolic, Oncologic and Autoimmune Diseases
|
|
WO2016183120A1
(en)
|
2015-05-13 |
2016-11-17 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
|
EP3294717B1
(en)
|
2015-05-13 |
2020-07-29 |
Vertex Pharmaceuticals Inc. |
Methods of preparing inhibitors of influenza viruses replication
|
|
TW201815787A
(zh)
|
2016-09-23 |
2018-05-01 |
美商基利科學股份有限公司 |
磷脂醯肌醇3-激酶抑制劑
|
|
TW201825465A
(zh)
|
2016-09-23 |
2018-07-16 |
美商基利科學股份有限公司 |
磷脂醯肌醇3-激酶抑制劑
|
|
TW201813963A
(zh)
|
2016-09-23 |
2018-04-16 |
美商基利科學股份有限公司 |
磷脂醯肌醇3-激酶抑制劑
|
|
US10421765B2
(en)
|
2017-05-26 |
2019-09-24 |
Board Of Regents, The University Of Texas System |
Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase
|
|
ES2974334T3
(es)
|
2017-07-13 |
2024-06-26 |
Univ Texas |
Inhibidores heterocíclicos de ATR cinasa
|
|
CN111886224B
(zh)
|
2017-08-17 |
2024-07-23 |
德州大学系统董事会 |
Atr激酶的杂环抑制剂
|
|
JP7341156B2
(ja)
|
2018-03-16 |
2023-09-08 |
ボード オブ レジェンツ，ザ ユニバーシティ オブ テキサス システム |
Ａｔｒキナーゼの複素環式阻害剤
|
|
JP2021098692A
(ja)
|
2019-12-20 |
2021-07-01 |
ヌエヴォリューション・アクティーゼルスカブＮｕｅｖｏｌｕｔｉｏｎ Ａ／Ｓ |
核内受容体に対して活性の化合物
|
|
AU2021249530A1
(en)
|
2020-03-31 |
2022-12-01 |
Nuevolution A/S |
Compounds active towards nuclear receptors
|
|
AU2021245397A1
(en)
|
2020-03-31 |
2022-10-20 |
Nuevolution A/S |
Compounds active towards nuclear receptors
|
